We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
About Biomedical Basics
Biomedical Basics are AI-generated explanations prepared with access to the complete collection, human-reviewed prior to publication. Short and simple, covering biomedical and life sciences fundamentals.
Topics Covered
- Toxicological safety assessment
- Chemical properties in toxicity
- Regulatory standards and guidelines
- Dose-response relationships
- Organ-specific toxicity mechanisms
- In vitro and in vivo methods
- Risk assessment and safe doses
- Good Laboratory Practice compliance
- Ethics and three Rs principles
Talk Citation
(2026, October 29). Toxicology in drug development [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 29, 2026, from https://doi.org/10.69645/ZTHK5470.Export Citation (RIS)
Publication History
- Published on October 29, 2026
Financial Disclosures
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome to this lecture on
toxicology and drug development,
providing an overview of
early safety assessment
methods in toxicology,
including how chemical
properties, metabolism,
and exposure influence toxicity,
and the key regulatory
standards that guide testing.
We will discuss
the importance of
the dose response relationship,
approaches for establishing
safe starting doses
and the concept of
safety margins.
The presentation will also
address mechanisms of organ
specific toxicity using both
in vitro and in vivo models,
as well as current
best practices and
innovative alternatives in
preclinical safety evaluation.
Finally, we will
highlight the integration
of regulatory guidelines to
ensure ethical and effective
toxicological assessment
throughout drug development.
Toxicology is a critical
component of drug development,
ensuring new medicines
are safe for human use.
Early safety assessments
identify and
mitigate potential hazards
posed by new compounds.
Key principles involve
understanding how
chemical properties,
metabolism, and exposure
influence toxicity.
Regulatory authorities
like the FDA,
EMA, and ICH set global
safety standards.
Risk assessment
and safety margins
help establish an acceptable
benefit risk balance.
Safety evaluation is continuous,
guiding selection, dosing,
and ongoing development.
A foundational concept in
toxicology is the dose
response relationship.
The dose makes the poison.
The severity and incidence of